Application note: Characterization of hGABAA α1β3γ2 on Nanion's SyncroPatch 96

Application note: Characterization of rNaV1.8 (ND7-23) on Nanion's SyncroPatch 96

Application note: Characterization of hGABAA α5β3γ2 on Nanion's SyncroPatch 96

Application note: High Throughput Pharmacology of CaV1.2 Channels on Nanion’s SyncroPatch 384PE

Application note: Pharmacology on rNaV1.7 performed on Nanion‘s SyncroPatch 96

Application note: Different modes of activation of CFTR recorded on Nanion’s SyncroPatch 384PE

Application note: Stability and Pharmacology of CaV1.2 Channels on Nanion’s SyncroPatch 384PE

Application note: Stability and reproducibility of hNaV1.8 recordings on Nanion's SyncroPatch 384PE

Application note: Activation and inhibition of TREK-1 on Nanion’s SyncroPatch 384PE

Application Note - Activation, potentiation and inhibition of AMPA receptors on the SyncroPatch 384PE

Qualification of Patch Ready Cells on a SyncroPatch 384PE

Application Note - NaV1.5-ΔKPQ late INa current properties and pharmacology on the SyncroPatch 384i

Application Note - Increase throughput by recording in unattended mode on the SyncroPatch 384

Application Note - Characterization of hClC-1 on the SyncroPatch 384

Application Note - Stable Recordings and High Throughput Pharmacology of Assay Ready CaV1.2 Cells on the SyncroPatch 384

Application Note - "High Throughput Pharmacology of NaV1.9 Channels on Nanion’s SyncroPatch 384"

Application Note - Reproducible activation and pharmacology of hTRPA1 on the SyncroPatch 384

Application Note - Assay Ready TRP-Channel Expressing Cells - a Flexible Tool to Screen for New Drug Candidates

Application note:The role of LRRC8 in the hypotonic stress response of human keratinocytes

Application Note - "There is no F in APC: Reliable fluoride-free recordings on the SyncroPatch 384"